Oracle Corp (NYSE:ORCL) shares are up during Friday’s premarket session as a 10-year defense contract win helps keep buyers engaged even as the broader risk tone is only modestly positive.
S&P 500 futures are up 0.3%, giving the stock a supportive backdrop heading into the open.
$7 Billion Defense Contract Matters
The U.S. Defense Department awarded Oracle a 10-year, nearly $7 billion enterprise software agreement negotiated by the Department of the Navy, marking the first direct award contract covering the department’s on-premises Oracle usage.
Notably, this contract valued at $3.31 billion for the first five years and potentially $6.99 billion if options are exercised, streamlines procurement processes for Oracle’s commercial products and services.
The Pentagon said the deal consolidates licensing, improves visibility into usage and spending, and is expected to drive at least $441 million in taxpayer savings.
Oracle Stock: Critical Levels To Watch
Even with the contract headline, the longer-term chart is still in “repair mode”: the stock is down 50.57% over the past 12 months and is trading 34.8% below its 200-day SMA, a sign the primary trend remains bearish. It’s also trading 29% below its 50-day SMA, and the 50-day SMA remains below the 200-day SMA following the death cross in January.
Momentum is the more interesting near-term tell right now, with RSI at 29.08—an oversold reading that often signals selling pressure has become stretched, and conditions may be setting up for a bounce if buyers can defend nearby lows. That said, oversold doesn’t equal “bottom,” and the stock’s recent swing low in July keeps the focus on whether price can build a base rather than just snap back briefly.
From a levels perspective, the stock is sitting close to the bottom of its 52-week range ($119.44 to $345.72), which can attract dip-buying but also increases the risk of breakdowns if support fails. A practical “trend check” for any rebound attempt is whether price can start reclaiming short-term averages like the 20-day SMA, since it’s currently 9.9% below that level.
- Key Resistance: $136.28 — aligns with the 20-day SMA, a common first hurdle in oversold rebound attempts
- Key Support: $119.44 — the 52-week low zone, which is the most immediate downside reference
Oracle Earnings Preview: What Analysts Expect for September 2026
Looking further out, the next major catalyst for the stock arrives with the September 8, 2026 (estimated) earnings report.
- EPS Estimate: $1.67 (Up from $1.47 YoY)
- Revenue Estimate: $19.12 Billion (Up from $14.93 Billion YoY)
- Valuation: P/E of 20.6x (Suggests fair valuation relative to peers)
Analyst Consensus & Recent Actions: The stock carries a Buy rating with an average price forecast of $260.04 (with targets ranging from $145.00 to $400.00 across 50 analysts). Recent analyst moves include:
- CLSA: Initiated with Hold (Target $145.00) (July 20)
- Bernstein: Outperform (Raises Target to $325.00) (June 11)
- RBC Capital: Sector Perform (Maintains Target $190.00) (June 11)
Oracle (ORCL) ETF Exposure: Key Funds to Watch
- iShares Expanded Tech-Software Sector ETF (BATS:IGV): 5.87% Weight
- First Trust NASDAQ Technology Dividend Index Fund (NASDAQ:TDIV): 9.82% Weight
- Pacer Data and Digital Revolution ETF (NYSE:TRFK): 7.57% Weight
Significance: Because ORCL carries such a heavy weight in these funds, any significant inflows or outflows for these ETFs will likely force automatic buying or selling of the stock.
ORCL Price Action: Oracle shares were up 2.24% at $122.72 during premarket trading on Friday. The stock is trading near its 52-week low of $119.44, according to Benzinga Pro data.
Photo via Shutterstock
